Qi Li

机构：Zhejiang Cancer Hospital · ORCID：0000-0003-2588-6541

发表论文 57 篇 · 总被引 2407 次 · h-index 20

代表论文

• Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial (2022 · Cancer Cell · 被引 578)
• Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma (2023 · JAMA · 被引 250)
• Targeting Protein Kinase C for Cancer Therapy (2022 · Cancers · 被引 77)
• Intravenous Tenecteplase before Thrombectomy in Stroke (2025 · New England Journal of Medicine · 被引 70)
• Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages (2021 · Journal of Experimental & Clinical Cancer Research · 被引 48)
• Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer (2022 · Journal of the National Cancer Center · 被引 28)